Clinical Trials Search at Vanderbilt-Ingram Cancer Center

Atezolizumab + Sacituzumab Govitecan to Prevent Recurrence in TNBC (ASPRIA)

Breast

The purpose of this study is to determine if a combination of two drugs sacituzumab govitecan and atezolizumab works as a treatment for residual cancer in the breast or lymph nodes and have circulating tumor DNA in the blood.

This research study involves the following investigational drugs:

* Sacituzumab govitecan
* Atezolizumab

Disease Sites: Breast

Phase: II

Investigator: Abramson, Vandana

NCTID: NCT04434040

Protocol No: VICCBRE2056

High-Resolution Specimen PET-CT Imaging for the Intraoperative Visualization of Resection Margins: An Exploratory Study

Miscellaneous

Disease Sites: Miscellaneous

Phase: I

Investigator: Topf, Michael

NCTID:

Protocol No: VICCHNP24616

Window Trial of Fluorescently Labeled Panitumumab (Panitumumab-IRDye800) in Head and Neck Cancer

Multiple Cancer Types

Disease Sites: Head/Neck, Phase I

Phase: I

Investigator: Rosenthal, Eben

NCTID:

Protocol No: VICCHNP24602

Pilot Study Assessment of Bone Mineral Density Changes During Treatment with Anti-PD-1 Immunotherapy Agents

Miscellaneous

Disease Sites: Miscellaneous

Phase: N/A

Investigator: Sharpe, Jessica

NCTID:

Protocol No: VICCMD25019

A Phase 2, Open-Label, Randomized, Multicenter Study to Evaluate the Safety and Efficacy of Axatilimab in Combination With Ruxolitinib in Participants With Newly Diagnosed Chronic Graft-Versus-Host Disease

Disease Sites: Not Available

Phase: II

Investigator: Kitko, Carrie

NCTID:

Protocol No: VICC-DTCTT24000

Clinical Trial Flowcharts
for Referring Physicians

Clinical Trial Flowcharts
for VICC Staff (VUNetID required)

Clinical Trials Search CTA Inline Referral Form